news

WASHINGTON, D.C. – Congresswoman Debbie Dingell (MI-12) announced today that the University of Michigan, Eastern Michigan University, Arborsense, Evoq Therapeutics, and Altarum Institute will receive $7,812,956 in grant funding from the Department of Health and Human Services (HHS) to conduct cancer, diabetes, clinical, and drug use and addiction research.

“Michigan’s 12^th Congressional District is home to groundbreaking health care research that is ushering in the next generation of treatments and cures for patients and families,” said Dingell. “With nearly $8 million in federal grant funding from HHS, we will empower organizations, including the University of Michigan and Eastern Michigan University, to continue critical research that will make a meaningful difference in lives throughout this country and around the world.”

Grant Recipients:

• The University of Michigan will receive $4,952,195 to continue a host of critical medical research programs
• Eastern Michigan University will receive $445,500 for Pharmacology, Physiology, and Biological Chemistry Research
• Arborsense, Inc. in Ann Arbor, will receive $868,719 for Drug Abuse and Addiction Research Programs
• Evoq Therapeutics, LLC in Ann Arbor, will receive $287,733 for Allergy, Immunology, and Transplantation Research
• Altarum Institute in Ann Arbor, will receive $1,258,809 for Innovations in Newborn Screening Interoperability

HHS is the largest grant-making agency in the US. Most HHS grants are provided directly to states, territories, tribes, and educational and community organizations, then distributed to eligible individuals and organizations. For more information on HHS grants click here.